- cafead   Mar 15, 2023 at 11:32: AM
via Backed by an impressive cadre of pharma leaders including Novartis and Pfizer, Mediar Therapeutics added another $85 million to its coffers Wednesday to take its first-in-class fibrosis therapies to the clinic.
article source
article source